Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Epidemiol Infect ; 145(1): 181-186, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27671461

RESUMEN

In Norway, no published data on seroprevalence of hepatitis E virus (HEV) in humans and swine exists. Serum samples from blood donors, veterinarians, swine farm workers and swine were analysed by ELISA to estimate the seroprevalence of HEV in Norway and to investigate the association between direct contact with swine and HEV seroprevalence in humans. The seroprevalence of HEV IgG antibodies was 30% (24/79) in farm workers, 13% (21/163) in veterinarians, 14% (162/1200) in blood donors and 90% (137/153) in swine. Our results show a high seroprevalence of HEV in humans and swine in Norway. HEV seroprevalence in farm workers and blood donors increased with age, and veterinarians working with swine were twice as likely to be HEV seropositive compared to other veterinarians. High HEV seroprevalence in farm workers and veterinarians working with swine support previous reports suggesting swine as a reservoir for HEV infections in humans in Europe.


Asunto(s)
Hepatitis E/epidemiología , Hepatitis E/veterinaria , Enfermedades de los Porcinos/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Animales , Ensayo de Inmunoadsorción Enzimática , Femenino , Anticuerpos Antihepatitis/sangre , Humanos , Inmunoglobulina G/sangre , Masculino , Persona de Mediana Edad , Noruega/epidemiología , Exposición Profesional , Estudios Seroepidemiológicos , Encuestas y Cuestionarios , Porcinos , Adulto Joven
2.
Epidemiol Infect ; 144(8): 1756-60, 2016 06.
Artículo en Inglés | MEDLINE | ID: mdl-26586305

RESUMEN

We investigated a nationwide outbreak of Salmonella Coeln in Norway, including 26 cases identified between 20 October 2013 and 4 January 2014. We performed a matched case-control study, environmental investigation and detailed traceback of food purchases to identify the source of the outbreak. In the case-control study, cases were found to be more likely than controls to have consumed a ready-to-eat salad mix (matched odds ratio 20, 95% confidence interval 2·7-∞). By traceback of purchases one brand of ready-to-eat salad was indicated, but all environmental samples were negative for Salmonella. This outbreak underlines that pre-washed and bagged salads carry a risk of infection despite thorough cleaning procedures by the importer. To further reduce the risk of infection by consumption of ready-to-eat salads product quality should be ensured by importers. Outbreaks linked to salads reinforce the importance of implementation of appropriate food safety management systems, including good practices in lettuce production.


Asunto(s)
Brotes de Enfermedades , Comida Rápida/microbiología , Enfermedades Transmitidas por los Alimentos/epidemiología , Infecciones por Salmonella/epidemiología , Salmonella/clasificación , Salmonella/aislamiento & purificación , Verduras/microbiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Niño , Preescolar , Femenino , Enfermedades Transmitidas por los Alimentos/microbiología , Humanos , Masculino , Persona de Mediana Edad , Noruega/epidemiología , Infecciones por Salmonella/microbiología , Encuestas y Cuestionarios , Adulto Joven
3.
Euro Surveill ; 14(46)2009 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-19941797

RESUMEN

During the 2007-08 influenza season, high levels of oseltamivir resistance were detected among influenza A(H1N1) viruses ina number of European countries. We used surveillance data to describe influenza A(H1N1) cases for whom antiviral resistance testing was performed. We pooled data from national studies to identify possible risk factors for infection with a resistant virus and to ascertain whether such infections led to influenza illness of different severity. Information on demographic and clinical variables was obtained from patients or their physicians. Odds ratios for infection with an oseltamivir resistant virus and relative risks for developing certain clinical outcomes were computed and adjusted through multivariable analysis. Overall, 727 (24.3%) of 2,992 tested influenza A(H1N1) viruses from 22 of 30 European countries were oseltamivir-resistant. Levels of resistance ranged from 1% in Italy to 67% in Norway. Five countries provided detailed case-based data on 373 oseltamivir resistant and 796 susceptible cases. By multivariable analysis, none of the analysed factors was significantly associated with an increased risk of infection with anoseltamivir-resistant virus. Similarly, infection with an oseltamivir-resistant virus was not significantly associated with a different risk of pneumonia, hospitalisation or any clinical complication. The large-scale emergence of oseltamivir-resistant viruses in Europe calls for a review of guidelines for influenza treatment.


Asunto(s)
Antivirales/farmacología , Brotes de Enfermedades , Farmacorresistencia Viral , Subtipo H1N1 del Virus de la Influenza A/efectos de los fármacos , Gripe Humana/virología , Oseltamivir/farmacología , Adolescente , Adulto , Anciano , Estudios de Casos y Controles , Niño , Preescolar , Estudios de Cohortes , Farmacorresistencia Viral/genética , Europa (Continente)/epidemiología , Femenino , Humanos , Lactante , Recién Nacido , Subtipo H1N1 del Virus de la Influenza A/clasificación , Subtipo H1N1 del Virus de la Influenza A/genética , Gripe Humana/epidemiología , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Guías de Práctica Clínica como Asunto , Estudios Retrospectivos , Riesgo , Factores de Riesgo , Estaciones del Año , Encuestas y Cuestionarios , Resultado del Tratamiento , Adulto Joven
4.
Epidemiol Infect ; 137(11): 1548-57, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19296867

RESUMEN

In 2006, in The Netherlands, an outbreak of Salmonella Typhimurium phage type 561 (STM DT7, corresponding to the rare DT7 in the international typing scheme) was detected, accumulating to over 200 cases. By telephone interviews, data were collected from all laboratory-confirmed cases. In addition, in August 2006, a case-control study was performed in a subset of cases. Environmental and microbiological investigation was performed on a suspected dairy farm. In the case-control study (51 cases, 105 matched controls), hard cheese purchased from a farm, specifically farm X, and from a market stall were found to be associated with infection. The dairy production room of farm X tested STM DT7-positive in August. However, it was only in November, after earlier unsuccessful attempts, that a low-level contamination was confirmed in the hard farmhouse cheese, triggering control measures. A timely and adequate response was hampered during this outbreak for several reasons. Measures for improvement in handling future similar incidents are discussed.


Asunto(s)
Queso/microbiología , Brotes de Enfermedades , Leche/microbiología , Salmonella typhimurium/aislamiento & purificación , Animales , Tipificación de Bacteriófagos , Estudios de Casos y Controles , Bovinos , Industria Lechera , Industria de Procesamiento de Alimentos , Humanos , Países Bajos/epidemiología , Intoxicación Alimentaria por Salmonella/epidemiología , Salmonelosis Animal/transmisión , Salmonella typhimurium/clasificación
6.
Eur Respir J ; 32(2): 419-25, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18353853

RESUMEN

The aim of the present study was to evaluate yield and effectiveness of a large-scale contact investigation around a supermarket employee with infectious tuberculosis. Supermarket customers were screened by tuberculin skin test (TST) and/or radiography, depending on individual characteristics. The number of recent infections was estimated based on historical reference data after correction for false-positive TST results. TST screening of 15,518 subjects yielded 12 cases of tuberculosis disease as a direct result of the investigation (1,293 screenings per case identified). Radiographical screening of 5,945 subjects yielded no cases. There were 359 (2.6%) positive TSTs; 117 (34%) were estimated to be due to recent exposure. The number of customers screened in order to find one case of recent infection was 114, varying from 43 for customers who visited the supermarket twice per week or more, to 4,148 for customers who visited less than once per month. In conclusion, although this patient probably transmitted Mycobacterium tuberculosis to at least 117 customers, the contact investigation was inefficient, as large numbers of customers had to be screened and the majority of identified tuberculosis infections were probably not related to the index case. The efficiency could have been improved by omitting radiographical screening and limiting tuberculin skin test screening to customers who reported frequent supermarket visits.


Asunto(s)
Trazado de Contacto , Mycobacterium tuberculosis/metabolismo , Prueba de Tuberculina/métodos , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/epidemiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Reacciones Falso Positivas , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Países Bajos , Tuberculosis Pulmonar/transmisión
7.
Ned Tijdschr Geneeskd ; 151(2): 142-3, 2007 Jan 13.
Artículo en Holandés | MEDLINE | ID: mdl-17315494

RESUMEN

Previous publications have indicated that between 2002 and 2003 in the Netherlands, the antimicrobial resistance in gonococci increased. Repeat measurements in 2004 and 2005 suggest a further increase in resistance ofgonococci, to quinolones in particular, from 7% in 2002 to 26% in 2005. National surveillance of gonococcal antimicrobial resistance is important for public health. In 2006 a further survey will be implemented, in which resistance data and epidemiological information on the patients are combined and collected in a project called 'Gonococcal resistance to antimicrobials surveillance' (GRAS).


Asunto(s)
Antibacterianos/farmacología , Gonorrea/tratamiento farmacológico , Neisseria gonorrhoeae/efectos de los fármacos , Quinolonas/farmacología , Relación Dosis-Respuesta a Droga , Farmacorresistencia Bacteriana , Humanos , Pruebas de Sensibilidad Microbiana , Países Bajos , Resultado del Tratamiento
8.
Euro Surveill ; 11(1): 37-9, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16484731

RESUMEN

In 2004, an outbreak of hepatitis A occurred in European tourists returning from Egypt. The reported hepatitis A attack rates varied considerably between tourists from different European countries. To determine the reason for this divergence in attack rates, a survey was undertaken with the following objectives: (a) documentation of national hepatitis A prevention policies for people travelling to Egypt and (b) documentation of hepatitis A reporting practices in these countries. A questionnaire was compiled and distributed to 13 European countries. All eight of the countries that responded had produced guidelines for the prevention of travel-associated hepatitis A. Between 2001-2003, 40% (range 4-51) of hepatitis A cases reported annually were associated with travel abroad. This occurred despite the fact that all countries recommended active vaccination with hepatitis A vaccine for people travelling to Egypt for holidays. There was no standard case definition for reporting confirmed cases in the countries that reported hepatitis A cases. As it is likely that travel-associated infections will increase as more people take overseas holidays, innovative ways to increase the number of travellers who seek and adhere to appropriate medical advice prior to travel must be explored. In addition, we recommend the use of the European Commission case definition for notification of confirmed cases of hepatitis A.


Asunto(s)
Política de Salud , Hepatitis A/prevención & control , Viaje , Vacunación , Egipto , Europa (Continente) , Humanos , Encuestas y Cuestionarios
9.
Euro Surveill ; 11(1): 7-8, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-29208165

RESUMEN

In 2004, an outbreak of hepatitis A occurred in European tourists returning from Egypt. The reported hepatitis A attack rates varied considerably between tourists from different European countries. To determine the reason for this divergence in attack rates, a survey was undertaken with the following objectives: (a) documentation of national hepatitis A prevention policies for people travelling to Egypt and (b) documentation of hepatitis A reporting practices in these countries. A questionnaire was compiled and distributed to 13 European countries. All eight of the countries that responded had produced guidelines for the prevention of travel-associated hepatitis A. Between 2001-2003, 40% (range 4-51) of hepatitis A cases reported annually were associated with travel abroad. This occurred despite the fact that all countries recommended active vaccination with hepatitis A vaccine for people travelling to Egypt for holidays. There was no standard case definition for reporting confirmed cases in the countries that reported hepatitis A cases. As it is likely that travel-associated infections will increase as more people take overseas holidays, innovative ways to increase the number of travellers who seek and adhere to appropriate medical advice prior to travel must be explored. In addition, we recommend the use of the European Commission case definition for notification of confirmed cases of hepatitis A.

10.
Int J Food Microbiol ; 64(1-2): 89-94, 2001 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-11252515

RESUMEN

Avoparcin was used as a growth promoting feed additive in Norwegian broiler and turkey production from 1986 until it was banned in 1995, when an association between vancomycin-resistant enterococci (VRE) and avoparcin use became apparent. A recent study regarding faecal samples documented a continuing high prevalence of VRE among Norwegian poultry 3 years after avoparcin was banned. In the present study, carcasses of broilers and turkeys from farms where avoparcin had previously been in use and carcasses of layer chickens from farms where avoparcin had never been used were examined for the presence of VRE. One carcass from each of 150 different farms was included. By a direct plating method, VRE were isolated from 30 of 100 samples of broilers and turkeys, but not from any samples of layer chickens. When an enrichment step was included, VRE were isolated from a total of 81 of the 100 samples of broilers and turkeys and from nine of the 50 samples of layer chickens. All VRE isolated were highly resistant to vancomycin (MIC > or = 256 microg/ml) and possessed the vanA gene. These results correspond to the prevalence of VRE recently documented in faecal samples from Norwegian poultry. The present study reveals a high prevalence of VRE in broiler and turkey carcasses. Consequently, consumers are exposed to VRE when handling raw poultry meat, although the public health significance of such exposure is unclear.


Asunto(s)
Antibacterianos/administración & dosificación , Antibacterianos/efectos adversos , Pollos/microbiología , Enterococcus/aislamiento & purificación , Glicopéptidos , Pavos/microbiología , Animales , Proteínas Bacterianas , Ligasas de Carbono-Oxígeno , Enterococcus/efectos de los fármacos , Heces/microbiología , Microbiología de Alimentos , Pruebas de Sensibilidad Microbiana , Noruega , Prevalencia , Resistencia a la Vancomicina
11.
J Appl Microbiol ; 89(3): 478-85, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11021580

RESUMEN

Avoparcin was used as a feed additive in Norwegian broiler and turkey production from 1986 until 1995. It was banned due to the selection of VanA-type vancomycin-resistant enterococci (VRE) in animal husbandry and to reduce the potential for human exposure to VRE. The aim of the present study was to investigate the prevalence of VRE carriage in Norwegian poultry farmers and their poultry three years after avoparcin was banned. Corresponding faecal samples from poultry and humans on farms where avoparcin had previously been used (exposed farms, n = 73) and farms where avoparcin had never been used (unexposed farms, n = 74) were analysed for the presence of VRE. For each farm, one sample from the poultry house and one sample from the farmer were obtained. VRE were isolated from 72 of 73 (99%) and eight of 74 (11%) poultry samples from exposed and unexposed farms, respectively. VRE were isolated from 13 of 73 (18%) and one of 74 (1%) farmer samples from exposed and unexposed farms, respectively. All VRE isolates were highly resistant to vancomycin and possessed the vanA gene, as shown by PCR. The high prevalence of VRE is in accordance with previous Norwegian studies, and shows a remarkable stability of the VanA resistance determinant in an apparently non-selective environment.


Asunto(s)
Antibacterianos/farmacología , Enterococcus/efectos de los fármacos , Aves de Corral/microbiología , Crianza de Animales Domésticos , Animales , Proteínas Bacterianas/análisis , Proteínas Bacterianas/genética , Ligasas de Carbono-Oxígeno/análisis , Ligasas de Carbono-Oxígeno/genética , Farmacorresistencia Microbiana , Electroforesis en Gel de Campo Pulsado , Enterococcus/genética , Heces/microbiología , Glicopéptidos , Humanos , Noruega , Vancomicina/farmacología , Resistencia a la Vancomicina
12.
FEMS Microbiol Lett ; 191(2): 255-8, 2000 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-11024272

RESUMEN

Five Norwegian broiler farms previously identified as housing broilers carrying vancomycin-resistant enterococci (VRE) were examined for the presence of VRE 4 years after avoparcin was banned. Environmental samples were obtained from empty, cleaned broiler houses. Faecal samples were collected weekly from the flock housed after the environmental sampling. The hatchery from where the chicks originated was also sampled. VRE were found to be present in the farm environment after depopulation and cleanup of the broiler houses. Within 3 weeks after introduction to the farm, all broiler flocks tested positive for VRE. VRE were not isolated from the hatchery.


Asunto(s)
Pollos/microbiología , Enterococcus/aislamiento & purificación , Resistencia a la Vancomicina , Crianza de Animales Domésticos , Animales , Proteínas Bacterianas/genética , Ligasas de Carbono-Oxígeno/genética , Enterococcus/efectos de los fármacos , Enterococcus/genética , Microbiología Ambiental , Heces/microbiología , Pruebas de Sensibilidad Microbiana , Noruega , Reacción en Cadena de la Polimerasa
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA